Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 406 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Feasibility of Intraoperative Microdialysis (tissue sampling) during Neurosurgery for Central Nervous System Malignancies

    Rochester, MN

  2. 3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer

    Rochester, MN

  3. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Rochester, MN

  5. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases

    Rochester, MN

  7. A Study to Evaluate Visually Inspired Patient Education Material on Willingness to Pursue Radiation Therapy

    Scottsdale/Phoenix, AZ

  8. ALPN-202 With PD-1 Inhibition in Advanced Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer

    Rochester, MN

  10. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

    Rochester, MN

.

Mayo Clinic Footer